Fly News Breaks for March 2, 2020
Mar 2, 2020 | 08:45 EDT
Wedbush analyst Liana Moussatos lowered the firm's price target on BioMarin to $164 from $175 following quarterly results and guidance. The analyst keeps an Outperform rating on the shares.
News For BMRN From the Last 2 Days
There are no results for your query BMRN